Today: 30 June 2026
SanDisk stock today: SNDK rebounds from early dip as year-end trade thins
30 December 2025
1 min read

SanDisk stock today: SNDK rebounds from early dip as year-end trade thins

NEW YORK, December 30, 2025, 11:41 ET — Regular session

  • Sandisk shares rose in late morning trading after slipping more than 3% earlier.
  • Year-end positioning has kept a spotlight on the S&P 500’s top 2025 gainers.
  • Traders are watching Fed minutes and jobless claims in a thin holiday-shortened week.

Sandisk Corp shares rose 0.8% to $246.30 in late morning trade on Tuesday after dropping as much as 3.1% earlier in the session. The stock ranged from $236.64 to $246.84.

The year-end tape has put Sandisk back on watchlists because it has been one of 2025’s biggest winners. Kiplinger recently ranked SanDisk as the S&P 500’s top gainer for the year, up about 594%, alongside storage and memory peers Western Digital, Micron Technology and Seagate Technology.

That kind of run can cut both ways in the final week of the year. With many managers closing books and rebalancing, small flows can amplify moves in momentum names.

The broader market backdrop has stayed choppy, with technology shares under renewed pressure in thin volumes ahead of the New Year’s Day holiday, when U.S. markets will be closed on Thursday. “I wouldn’t try to make too much out of anything that happens in a holiday-shortened week and very light trading volume,” said Art Hogan, chief market strategist at B Riley Wealth. Investors are also looking to minutes from the Federal Reserve’s December meeting and a weekly jobless claims reading for fresh rate clues. Reuters

For Sandisk, the mix of light liquidity and high expectations has made intraday reversals more common than in slower-moving large caps. Tuesday’s early slide and rebound fit that pattern.

Seasonal trading has added another layer. Investors have been watching for a “Santa Claus rally,” the market shorthand for gains that often show up in the last five trading days of the year and the first two in January. Reuters

Sandisk returned to public markets in 2025 after being separated from Western Digital’s flash business, with regular-way trading beginning on Nasdaq under the ticker “SNDK.” SEC

The company makes flash storage products, including solid-state drives, and sells into consumer and enterprise markets tied to data growth and cloud spending.

The sharp swing left clear price markers for traders. The $236–$240 area is now in focus after the morning low, while the mid-$240s to just under $247 marks the near-term ceiling from Tuesday’s high.

Investors will likely keep an eye on whether the stock can hold recent gains into the close, when year-end “window dressing” — portfolio tweaks meant to show favored holdings — can distort flows. They will also watch if storage and memory names move in lockstep with broader tech sentiment as the week winds down.

For now, Sandisk’s modest gain masks a wide intraday range — a reminder that year-end sessions can punish both late buyers and quick sellers when liquidity is thin.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop